We are live on ! Find out more
PRTC

PureTech Health

Delisted

PRTC was delisted on the 20th of May, 2026.

2 hedge funds and large institutions have $1.89M invested in PureTech Health in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

2.05% less ownership

Funds ownership: 2.3% → 0.25% (-2.1%)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $15.6M

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$15.6M
2
UBS Group
UBS Group
Switzerland
-$9.2K

PRTC Hedge Fund Activity: Q3 2022 in Review

2 of the 5,834 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q3 2022, worth a combined $1.89M — down 25% from $2.52M a quarter earlier.

Fund positioning in PRTC was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was AWM Investment Company, cutting an estimated $15.6M.

  • 2 institutional investors held PureTech Health (PRTC) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $1.89M of PureTech Health stock for Q3 2022, down 25% quarter-over-quarter.
  • 0 funds opened new PureTech Health positions in Q3 2022 and 0 closed out.
  • The largest PureTech Health seller in Q3 2022 was AWM Investment Company, an estimated $15.6M sold.

Based on aggregated 13F filings for Q3 2022.